New Financial and Research Models for Pediatric Orphan Drug Development: Focus on the NCATS TRND Program John ShenGurmit GrewalJohn C. McKew Leading Article 19 February 2014 Pages: 1 - 6
Analysis of the Factors Influencing the Spontaneous Reporting Frequency of Drug Safety Issues Addressed in the FDA’s Drug Safety Communications, Using FAERS Data Chieko IshiguroYasushi HinomuraTsutomu Matsuda Original Research Article 31 January 2014 Pages: 7 - 19
Drugs in Clinical Development for Tuberculosis: Summary and Table Adis Profile Summary 30 January 2014 Pages: 21 - 24
